Closing the Validation Gap in Immune Checkpoint Antibody R&D
Immune checkpoint antibody programs often stall between candidate discovery and functional validation. Integrated characterization and cell-based assays can reduce uncertainty, improve candidate selection, and accelerate immuno-oncology R&D.   Immune checkpoint antibodies remain central to immuno-oncology research, yet moving from an antibody candidate to a convincingly validated...
0 Комментарии 0 Поделились 197 Просмотры 0 предпросмотр